Business profile
Loading canonical business information.
About
Services
Products
Articles & research
Offers
Published by the business. Confirm current availability and terms with the business.
Browse productsPromotions
Published by the business. Confirm current availability and terms with the business.
Browse productsFrequently asked questions
Answers published by the business.
Published agent capabilities
Capabilities recorded in this listing. Their presence is not a live availability check.
AI-readable discovery
Read the structured business information and inspect the published discovery documents.
Machine-readable documents do not by themselves establish a live AI agent, checkout or business ownership.
Request a quote
Loading quote availabilityβ¦
Sources
Report this listing
Tell us what needs reviewing. Removal requests are reviewed before any change is made.
Request removalProfile information
Publication, owner access and business registry verification are separate. Verification badges describe the checks completed; public references identify this listing.
Structured public business summary
Novo Holdings
Novo Holdings is a world-leading life science investor with a focus on creating long-term value.
Denmark
Business nature
- Primary business nature
- Not provided
- Customer market
- Not provided
Operating hours
Hours not provided.
Categories
- Other Businesses & Services (primary)
Service areas
- Denmark
Public contacts
- Public email: info@novoholdings.dk
- Public phone: +45 3527 6500
- linkedin: https://www.linkedin.com/company/novo-a-s/
- linkedin: https://www.linkedin.com/company/novo-a-s/?viewAsMember=true
- linkedin: https://www.linkedin.com/company/myricx-pharma-ltd/
- twitter: https://twitter.com/novoholdings
- x: https://x.com/novoholdings
Declared AI capabilities
- Online support β Detected from public website navigation or discovery metadata.
Directory status
Registry verification: Not Registry Verified
Directory score: 80
Public source evidence
- Novo Holdings
- website
- Novo Holdings Β· News & Reports
- Novo Holdings Β· Novo Holdings announces acquisition of portfolio company LimmaTech Biologics by Lilly
- Novo Holdings Β· Novo Holdings portfolio company Hemab Therapeutics completes successful Nasdaq IPO
- Novo Holdings portfolio company Myricx Bio agrees to be acqu
- Novo Holding Β· FAQ
- Novo Holdings Β· About